International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct

Rao, S, Sclafani, F, Eng, C et al. (18 more authors) (2020) International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct. Journal of Clinical Oncology. ISSN 0732-183X

Abstract

Metadata

Authors/Creators:
  • Rao, S
  • Sclafani, F
  • Eng, C
  • Adams, RA
  • Guren, MG
  • Sebag-Montefiore, D https://orcid.org/0000-0002-5978-9259
  • Benson, A
  • Bryant, A
  • Peckitt, C
  • Segelov, E
  • Roy, A
  • Seymour, MT
  • Welch, J
  • Saunders, MP
  • Muirhead, R
  • O’Dwyer, P
  • Bridgewater, J
  • Bhide, S
  • Glynne-Jones, R
  • Arnold, D
  • Cunningham, D
Copyright, Publisher and Additional Information: © 2020 by American Society of Clinical Oncology. Reproduced in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 21 April 2020
  • Published (online): 12 June 2020
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 10 Jul 2020 11:18
Last Modified: 10 Jul 2020 11:18
Status: Published online
Publisher: American Society of Clinical Oncology
Identification Number: https://doi.org/10.1200/JCO.19.03266
Related URLs:

Download

Published Version


Embargoed until: 12 June 2021

Filename: jco.19.03266-2.pdf

Request a copy

Share / Export

Statistics